Titan Medical Inc. Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Notes Tables
Notes Details

COMMITMENTS

COMMITMENTS	3 Months Ended
Mar. 31, 2021
Commitments [abstract]
COMMITMENTS	10.COMMITMENTS As part of its program of research and development of the Enos system, the Company has outsourced certain aspects of the research and development to third party technology and development companies. At March 31, 2021, $5,369 in purchase orders remain outstanding (December 31, 2020: $10,694).

COMMITMENTS

3 Months Ended

Mar. 31, 2021

Commitments [abstract]

COMMITMENTS

10.COMMITMENTS

As part of its program of research and development of the Enos system, the Company has outsourced certain aspects of the research and development to third party technology and development companies. At March 31, 2021, $5,369 in purchase orders remain outstanding (December 31, 2020: $10,694).